Comparison of the pharmacokinetics of S-1, an oral anticancer agent, in Western and Japanese patients

av Comets, Emmanuelle, Ikeda, Kazumasa, Hoff, Paulo, Fumoleau, Pierre, Wanders, Jantien, Tanigawara, Yusuke
Publicerad 2003

Population pharmacokinetic and pharmacodynamic analysis to support treatment optimization of combination chemotherapy with indisulam and carboplatin

av Zandvliet, Anthe S, Schellens, Jan H M, Dittrich, Christian, Wanders, Jantien, Beijnen, Jos H, Huitema, Alwin D R
Publicerad 2008

Eribulin Monotherapy in Patients Aged 70 Years and Older With Metastatic Breast Cancer

av Muss, Hyman, Cortes, Javier, Vahdat, Linda T., Cardoso, Fatima, Twelves, Chris, Wanders, Jantien, Dutcus, Corina E., Yang, Jay, Seegobin, Seth, O’Shaughnessy, Joyce
Publicerad 2014

A model of hypertension and proteinuria in cancer patients treated with the anti-angiogenic drug E7080

av Keizer, Ron J., Gupta, Anubha, Mac Gillavry, Melvin R., Jansen, Mendel, Wanders, Jantien, Beijnen, Jos H., Schellens, Jan H. M., Karlsson, Mats O., Huitema, Alwin D. R.
Publicerad 2010

Predictive ability of a semi-mechanistic model for neutropenia in the development of novel anti-cancer agents: two case studies

av Soto, Elena, Keizer, Ron J., Trocóniz, Iñaki F., Huitema, Alwin D. R., Beijnen, Jos H., Schellens, Jan H. M., Wanders, Jantien, Cendrós, Josep María, Obach, Rosendo, Peraire, Concepción, Friberg, Lena E., Karlsson, Mats O.
Publicerad 2010

Pharmacokinetics of eribulin mesylate in patients with solid tumours receiving repeated oral rifampicin

av Devriese, Lot A, Witteveen, Petronella (Els) O, Wanders, Jantien, Law, Kenneth, Edwards, Geoff, Reyderman, Larisa, Copalu, William, Peng, Fuping, Marchetti, Serena, Beijnen, Jos H, Huitema, Alwin D R, Voest, Emile E, Schellens, Jan H M
Publicerad 2013